{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:38:03Z","timestamp":1784299083248,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302252"],"award-info":[{"award-number":["81302252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ygyno.2018.01.023","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:18:49Z","timestamp":1518157129000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["\u03b3-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K\/AKT\/mTOR pathway"],"prefix":"10.1016","volume":"149","author":[{"given":"Yanli","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2018.01.023_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0010","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1098-2388(200007\/08)19:1<11::AID-SSU3>3.0.CO;2-3","article-title":"Current management of epithelial ovarian carcinoma: a review","volume":"19","author":"Marsden","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","article-title":"Ovarian cancer: epidemiology, biology, and prognostic factors","volume":"19","author":"Holschneider","year":"2000","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/prca.200600468","article-title":"A novel tumor-related protein, C7orf24, identified by proteome differential display of bladder urothelial carcinoma","volume":"1","author":"Kageyama","year":"2007","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2006.05.161","article-title":"A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol","volume":"346","author":"Masuda","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0035","doi-asserted-by":"crossref","first-page":"22031","DOI":"10.1074\/jbc.M803623200","article-title":"The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle","volume":"283","author":"Oakley","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1126\/science.180.4081.33","article-title":"On the enzymology of amino acid transport","volume":"180","author":"Meister","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","volume":"52","author":"Meister","year":"1983","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0050","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.ejca.2010.04.015","article-title":"Identification of glia maturation factor beta as an independent prognostic predictor for serous ovarian cancer","volume":"46","author":"Li","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2105-7-202","article-title":"Profiling alternatively spliced mRNA isoforms for prostate cancer classification","volume":"7","author":"Zhang","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0060","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1471-2105-8-275","article-title":"Large-scale integration of cancer microarray data identifies a robust common cancer signature","volume":"8","author":"Xu","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0065","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/pr100160u","article-title":"Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker","volume":"9","author":"Gromov","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.humpath.2013.09.009","article-title":"Gamma-glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors","volume":"45","author":"Takemura","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0075","first-page":"385","article-title":"Localization and characterization of gamma-glutamyl cyclotransferase in cancer cells","volume":"2","author":"Azumi","year":"2009","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0080","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0021-9258(19)44083-0","article-title":"Glutamyl cyclotransferase. Distribution, isozymic forms, and specificity","volume":"248","author":"Orlowski","year":"1973","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0085","first-page":"1297","article-title":"Involvement of cancer biomarker C7orf24 in the growth of human osteosarcoma","volume":"31","author":"Uejima","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0090","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12858-016-0075-8","article-title":"Knockdown of GGCT inhibits cell proliferation and induces late apoptosis in human gastric cancer","volume":"17","author":"Zhang","year":"2016","journal-title":"BMC Biochem."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2015.08.010","article-title":"Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum","volume":"139","author":"Nakamura","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bbrc.2017.10.050","article-title":"Construction of artificial human peritoneal tissue by cell-accumulation technique and its application for visualizing morphological dynamics of cancer peritoneal metastasis","volume":"494","author":"Asano","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3892\/ijo.2013.1960","article-title":"Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3","volume":"43","author":"Meng","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0110","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1073\/pnas.1201029109","article-title":"Nonovarian origins of ovarian cancer","volume":"109","author":"Hillier","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/856f0890-9d85-4719-8e54-c27530ac94f4","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0120","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","journal-title":"J. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0135","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/CAD.0000000000000407","article-title":"Role of gamma-glutamyl cyclotransferase as a therapeutic target for colorectal cancer based on the lentivirus-mediated system","volume":"27","author":"Dong","year":"2016","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0145","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12885-016-2779-y","article-title":"Depletion of gamma-glutamylcyclotransferase inhibits breast cancer cell growth via cellular senescence induction mediated by CDK inhibitor upregulation","volume":"16","author":"Matsumura","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0150","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbrc.2016.01.165","article-title":"Gamma-glutamylcyclotransferase promotes the growth of human glioma cells by activating Notch-Akt signaling","volume":"471","author":"Shen","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0155","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrc1611","article-title":"Ovarian cancer metastasis: integrating insights from disparate model organisms","volume":"5","author":"Naora","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0165","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0170","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0175","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/gepi.21921","article-title":"Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk","volume":"39","author":"Amankwah","year":"2015","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0185","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5732\/cjc.014.10289","article-title":"The PI3K\/Akt\/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges","volume":"34","author":"Cheaib","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0190","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-05-0445","article-title":"Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT","volume":"5","author":"Sain","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0195","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0200","series-title":"Human Tumor Cells in Vitro","first-page":"115","article-title":"New human tumor cell lines","author":"Fogh","year":"1975"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/bjc.2015.471","article-title":"Cell line and patient derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer","volume":"114","author":"Harrington","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ygyno.2015.08.017","article-title":"Beyond genomics: critical evaluation of cell line utility for ovarian cancer research","volume":"139","author":"Elias","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0215","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2018.01.023_bb0220","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2018.01.023_bb0225","article-title":"Chemotherapy increases aggressiveness of prostate cancer via epithelial mesenchymal transition","volume":"2","author":"John J Kim","year":"2013","journal-title":"Cell Biol. Res. Ther."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825818300623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T03:25:45Z","timestamp":1660447545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825818300623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0090825818300623"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b3-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K\/AKT\/mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}